Recent Quotes
My Watchlist
Indicators
Local Stocks
NewsOK Local Stocks
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

22nd Century Group Inc (NY: XXII )

3.440 USD +0.030 (+0.88%)
Streaming Delayed Price Updated: 7:31 AM EST, Feb 26, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about 22nd Century Group Inc

< Previous 1 2 3 4 5 6 7 8 9
...
20 21 Next >
Thinking about buying stock in Anavex Life Sciences, Veru Inc, vTv Therapeutics, BioCardia, or 22nd Century Group?
InvestorsObserver issues critical PriceWatch Alerts for AVXL, VERU, VTVT, BCDA, and XXII. 
From PR Newswire
Thinking about buying stock in Walt Disney, vTv Therapeutics, 22nd Century Group, Lexicon Pharmaceuticals, or Ardelyx?
InvestorsObserver issues critical PriceWatch Alerts for DIS, VTVT, XXII, LXRX, and ARDX. 
From PR Newswire
Thinking about buying stock in Sorrento Therapeutics, Blink Charging, AMC Entertainment, 22nd Century Group, or Sunworks?
InvestorsObserver issues critical PriceWatch Alerts for SRNE, BLNK, AMC, XXII, and SUNW. 
From PR Newswire
Thinking about buying stock in Aptevo Therapeutics, Electrameccanica Vehicles, AstraZeneca, Corcept Therapeutics, or 22nd Century Group?
InvestorsObserver issues critical PriceWatch Alerts for APVO, SOLO, AZN, CORT, and XXII. 
From PR Newswire
Smokers Turn to CBD as a Tobacco Alternative
FinancialBuzz.com News Commentary 
From PR Newswire
CBD Could Help Smokers Move on From Tobacco
FinancialBuzz.com News Commentary 
From PR Newswire
CBD Offers Cigarette Smokers a New Way Out
FinancialBuzz.com News Commentary 
From PR Newswire
CBD Cigarettes Offer Tobacco Smokers a New Path to Quitting
FinancialBuzz.com News Commentary 
From PR Newswire
Tobacco Users Turn to CBD in Search of an Indicative Substitute
FinancialBuzz.com News Commentary 
From PR Newswire
Consumers Seek Alternatives to Tobacco as Use Slows
FinancialBuzz.com News Commentary 
From PR Newswire
Easing Regulations Place Psychedelic Medical Products on the Path to Growth
FinancialBuzz.com News Commentary 
From PR Newswire
22nd Century Group Appoints James A. Mish as Chief Executive Officer and John Franzino as Chief Financial Officer
From GlobeNewswire News Releases
Psychedelics Begin to Command Greater Stature in the Medical Field
FinancialBuzz.com News Commentary 
From PR Newswire
Researchers Delve Into Psychedelics in Search of Novel Therapies
FinancialBuzz.com News Commentary 
From PR Newswire
Consumers Look for Therapeutic Alternatives During Stressful Times
FinancialBuzz.com News Commentary 
From PR Newswire
Magic Mushroom Advocates Seek to Emulate the Rise of CBD
FinancialBuzz.com News Commentary 
From PR Newswire
22nd Century Group Reports First Quarter 2020 Financial Results
22nd Century Group, Inc. (NYSE American: XXII) (“22nd Century” or “the Company”), a leading plant biotechnology company focused on reduced nicotine tobacco and hemp/cannabis plant genetics research and... 
From Business Wire News Releases
Fervor for CBD Products Spreads Around the Globe
FinancialBuzz.com News Commentary 
From PR Newswire
22nd Century Group Completes Successful Non-GMO Very Low Nicotine Content Tobacco Research Field Trials
22nd Century Group, Inc. (NYSE American: XXII) (“22nd Century” or “the Company”), a leading plant biotechnology company focused on reduced nicotine tobacco and hemp/cannabis plant genetics research and... 
From Business Wire News Releases
Shifting Attitudes Towards Mental Health Open Doors to Innovative New Therapies
FinancialBuzz.com News Commentary 
From PR Newswire
FDA Announces Deadline to Submit Comments on 22nd Century Group’s MRTP Application
22nd Century Group achieves another important milestone in the FDA’s scientific review of the Company’s MRTP application for its reduced nicotine content cigarettes 
From GlobeNewswire News Releases
22nd Century Group, Inc. Files 2019 Annual Report
22nd Century Group, Inc. (NYSE American: XXII), a leading plant biotechnology company in reduced nicotine tobacco and hemp/cannabis plant genetics research and development, yesterday filed its Annual... 
From Business Wire News Releases
FDA Scientific Advisory Committee Discusses 22nd Century Group’s Reduced Nicotine Cigarettes
22nd Century Group, Inc. (NYSE American: XXII) — a plant biotechnology company that is a leader in reduced nicotine tobacco and hemp/cannabis plant research — met on Friday, February 14, 2020 with the... 
From Business Wire News Releases
22nd Century Group’s FDA Advisory Committee Meeting for Reduced Nicotine Content Cigarettes Brings New Standard for the Tobacco Industry
22nd Century Group, Inc. (NYSE American: XXII)—a plant biotechnology company that is a leader in tobacco harm reduction, reduced nicotine tobacco, and hemp/cannabis plant research—will present the... 
From Business Wire News Releases
Report Points to U.S. Vape Consumers Are Sticking with Vaping Products
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Report Points to U.S. Vape Consumers are Sticking with Vaping Products
Financialnewsmedia.com News Commentary 
From PR Newswire
CBD Stocks Snapshot - CBD/Hemp and Tobacco Deals (OTCQB: SING)
Tags s:washington h:worldnews c:united/states
From EIN Presswire
Shareholder Alert: Robbins LLP Reminds Investors 22nd Century Group, Inc. (XXII) Sued for Misleading Shareholders
Shareholder rights law firm Robbins LLP reminds investors that purchasers of 22nd Century Group, Inc. (NYSE: XXII) filed a class action complaint against the company for alleged violations of the... 
From Business Wire News Releases
22nd Century Group Files 2019 Third Quarter Report
22nd Century Group, Inc. (NYSE American: XXII), a plant biotechnology company that is a leader in tobacco harm reduction, Very Low Nicotine Content (VLNC) tobacco and hemp/cannabis research, announced... 
From Business Wire News Releases
Regulators Strive to Limit Illicit Cannabis Trade as the Industry Continues its Expansion
FinancialBuzz.com News Commentary 
From PR Newswire
< Previous 1 2 3 4 5 6 7 8 9
...
20 21 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.